Financhill
Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

Ultragenyx Pharmaceutical Price Quote

$44.46
+1.91 (+4.49%)
(Updated: July 22, 2024 at 6:55 PM ET)

Ultragenyx Pharmaceutical Key Stats

Sell
32
Ultragenyx Pharmaceutical (RARE) is a Sell

Day range:
$42.09 - $43.48
52-week range:
$31.52 - $54.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.40
P/B ratio:
27.47%

Volume:
606.8K
Avg. volume:
1M
1-year change:
-2.34%
Market cap:
$3.9B
Revenue:
$434.2M
EPS:
$-8.03

How Much Does Ultragenyx Pharmaceutical Make?

Is Ultragenyx Pharmaceutical Growing As A Company?

Ultragenyx Pharmaceutical Stock Price Performance

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

Is Ultragenyx Pharmaceutical Cash Flow Positive?

  • What Is RARE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$508.7M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $388.8M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $151.1M

Ultragenyx Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    RARE return on invested capital is -384.83%
  • What Is Ultragenyx Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is -45.56%
  • What Is RARE Return On Equity?
    ROE is a measure of profitability and is -384.83%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

Ultragenyx Pharmaceutical Competitors

Ultragenyx Pharmaceutical Dividend Yield

Data Unavailable

Ultragenyx Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -18.01%
Revenue: 8.3% -6.53%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 89.86
Upside from Last Price: 111.18%

Major Shareholders

  • How many RARE shares are owned by institutional investors?
    123.6M RARE shares are owned by institutional investors
  • How many RARE shares are owned by insiders?
    1.8M RARE shares are owned by insiders